Related Experiment Video
Updated: May 17, 2025
Assessing Hepatic Metabolic Changes During Progressive Colonization of Germ-free Mouse by 1H NMR Spectroscopy
Published on: December 15, 2011
A metabolomics and proteomics-based study on the metabolic effects of arecoline on the liver
Zhenjuan Cao1, Wenzhi Mai1, Lianfang Gan2
1School of Pharmacy, Hainan Medical University, Haikou, 571199, Hainan, China.
Abstract:
Arecoline is one of the primary constituents of the areca nut. Its pharmacological effects include analgesia, anti-inflammation, and anti-allergy. Current researches on the toxicity of arecoline mainly focuse on oral carcinogenesis and immunotoxicity, so there are relatively little systematic study on its hepatotoxicity and underlying mechanisms. Therefore, this study aims to explore the mechanisms of hepatotoxicity induced by different doses of arecoline in mice by integrating metabolomics and proteomics. In our pathological results, we found that the medium and high dose groups of arecoline can cause fatty degeneration in the livers of mice. Additionally, the different doses of arecoline increased the levels of ALT and AST in the serum of mice. Proteomics research identified that exposure to different doses of arecoline primarily affected the PPARs signaling pathway, thereby influencing fatty acid metabolism, amino acid metabolism, and arachidonic acid metabolism pathways. Metabolomics research identified differential metabolites in each group after arecoline exposure. We observed that with increasing doses of arecoline, the metabolites of lipids and lipid-like molecules in mice gradually increased. The results suggested arecoline may induce fatty degeneration in the liver of mice through the PPARα/Acox-1 mediated pathways of oxidative stress, inflammatory response, energy, and lipid metabolism.
Insights
Arecoline from areca nut causes liver damage, including fatty degeneration, in mice. This study reveals its mechanisms involve lipid metabolism disruption via the PPAR signaling pathway.
Area of Science:
- Toxicology
- Metabolomics
- Proteomics
Background:
- Arecoline, a key areca nut component, has known analgesic, anti-inflammatory, and anti-allergy effects.
- Existing research on arecoline toxicity primarily focuses on oral carcinogenesis and immunotoxicity, with limited data on hepatotoxicity.
- This study addresses the gap in understanding arecoline-induced liver injury mechanisms.
Purpose of the Study:
- To investigate the dose-dependent hepatotoxicity of arecoline in mice.
- To elucidate the underlying molecular mechanisms of arecoline-induced liver injury using metabolomics and proteomics.
- To identify key pathways and metabolites involved in arecoline's effects on liver health.
Main Methods:
- Mice were administered varying doses of arecoline.
- Liver pathology was assessed, and serum levels of ALT and AST were measured.
- Proteomics analysis was performed to identify affected signaling pathways.
- Metabolomics analysis was conducted to identify differential metabolites in response to arecoline exposure.
Main Results:
- Medium and high doses of arecoline induced fatty liver degeneration in mice.
- Arecoline exposure elevated serum ALT and AST levels.
- Proteomics revealed significant alterations in the PPARs signaling pathway, impacting lipid, amino acid, and arachidonic acid metabolism.
- Metabolomics showed a dose-dependent increase in lipid and lipid-like molecule metabolites.
Conclusions:
- Arecoline induces hepatotoxicity and fatty liver degeneration in a dose-dependent manner.
- The PPARα/Acox-1 pathway is implicated in arecoline-induced liver injury, involving oxidative stress, inflammation, and altered energy/lipid metabolism.
- These findings highlight potential risks associated with arecoline consumption and provide insights into its hepatotoxic mechanisms.
